Phong Phu Pharmaceutical JSC (HNX: PPP)
Vietnam
· Delayed Price · Currency is VND 16,600
-100 (-0.60%)
At close: Jan 24, 2025
HNX:PPP Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 23, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 148,720 | 155,760 | 130,240 | 113,520 | 154,880 | 99,440 | Upgrade
|
| Market Cap Growth | 19.59% | 19.59% | 14.73% | -26.70% | 55.75% | -38.92% | Upgrade
|
| Enterprise Value | 108,736 | 127,715 | 102,957 | 91,977 | 155,753 | 109,732 | Upgrade
|
| Last Close Price | 16900.00 | 17700.00 | 13870.16 | 10928.55 | 13910.67 | 8478.25 | Upgrade
|
| PE Ratio | 9.57 | 8.97 | 6.47 | 5.51 | 9.17 | 10.13 | Upgrade
|
| PS Ratio | 1.21 | 1.13 | 0.86 | 0.75 | 1.16 | 0.86 | Upgrade
|
| PB Ratio | 1.10 | 1.15 | 1.00 | 0.91 | 1.33 | 0.92 | Upgrade
|
| P/TBV Ratio | 1.31 | 1.31 | 1.15 | 1.07 | 1.59 | 1.13 | Upgrade
|
| P/FCF Ratio | 8.86 | 9.28 | 7.47 | 5.64 | 8.54 | 10.99 | Upgrade
|
| P/OCF Ratio | 8.98 | 8.98 | 6.51 | 5.42 | 8.03 | 9.75 | Upgrade
|
| EV/Sales Ratio | 0.79 | 0.93 | 0.68 | 0.61 | 1.17 | 0.94 | Upgrade
|
| EV/EBITDA Ratio | 4.45 | 5.23 | 3.68 | 2.93 | 6.02 | 5.81 | Upgrade
|
| EV/EBIT Ratio | 5.38 | 6.31 | 4.45 | 3.65 | 7.91 | 8.65 | Upgrade
|
| EV/FCF Ratio | 6.48 | 7.61 | 5.91 | 4.57 | 8.59 | 12.13 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | 0.02 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.08 | 0.59 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.11 | 1.23 | Upgrade
|
| Asset Turnover | 0.84 | 0.84 | 0.96 | 0.96 | 0.89 | 0.77 | Upgrade
|
| Inventory Turnover | 2.65 | 2.65 | 3.00 | 2.54 | 2.31 | 2.25 | Upgrade
|
| Quick Ratio | 1.65 | 1.65 | 1.59 | 1.21 | 0.74 | 0.63 | Upgrade
|
| Current Ratio | 2.89 | 2.89 | 2.71 | 2.35 | 1.80 | 1.76 | Upgrade
|
| Return on Equity (ROE) | 13.06% | 13.06% | 15.78% | 17.09% | 15.07% | 9.19% | Upgrade
|
| Return on Assets (ROA) | 7.73% | 7.73% | 9.09% | 10.02% | 8.19% | 5.24% | Upgrade
|
| Return on Capital (ROIC) | 9.51% | 9.51% | 11.34% | 12.95% | 10.37% | 6.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.92% | 14.92% | 17.71% | 20.18% | 16.86% | 11.17% | Upgrade
|
| Earnings Yield | 11.67% | 11.14% | 15.45% | 18.16% | 10.91% | 9.87% | Upgrade
|
| FCF Yield | 11.29% | 10.78% | 13.38% | 17.72% | 11.71% | 9.10% | Upgrade
|
| Dividend Yield | 7.23% | - | - | 12.81% | - | - | Upgrade
|
| Payout Ratio | 60.16% | 60.16% | 61.97% | 50.08% | 35.37% | 74.62% | Upgrade
|
| Buyback Yield / Dilution | -0.79% | -0.79% | 0.07% | 0.34% | 0.72% | -5.58% | Upgrade
|
| Total Shareholder Return | 6.44% | -0.79% | 0.07% | 13.16% | 0.72% | -5.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.